Qu Dacheng, Liu Yue, Jiang Jing, Shi Qiuling, Zhou Honggui, Wang Zhibiao
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Int J Hyperthermia. 2023;40(1):2193363. doi: 10.1080/02656736.2023.2193363.
To investigate the impact of ultrasound-guided high-intensity focused ultrasound (USgHIFU) on pregnancy in submucous leiomyomas.
Between October 2015 and October 2021, a retrospective observational study was conducted at the Affiliated Hospital of North Sichuan Medical College, China, for 32 women with submucous leiomyomas who became pregnant after USgHIFU. Pregnancy outcomes, submucous leiomyomas characteristics, and USgHIFU parameters were analyzed.
A total of 17 (53.1%) deliveries were successfully achieved, with full-term delivery in 16 (94.1%) patients and preterm delivery in 1 (5.9%). After USgHIFU, the effective volume in the uterus cavity and the volume of submucous leiomyomas shrank in all 32 patients. The median time to achieve pregnancy after USgHIFU was 11.0 months. Before pregnancy, myoma type was downgraded in 13 (40.6%) patients, stable in 10 (31.3%) and upgraded in 9 (28.1%). The vaginal expulsion rate of submucous leiomyomas was 28.1%, with complete expulsion in 3 (9.4%) patients and partial expulsion in 6 (18.8%). After USgHIFU, the size of submucous leiomyomas did not increase in each trimester (all > 0.05). The high complications rate during pregnancy (7/17, 41.2%) was associated with advanced maternal age, with only one (5.9%) premature rupture of membranes possibly associated with submucous leiomyomas. There were 6 (35.5%) vaginal delivery and 11 (64.7%) cesarean sections. All 17 newborns developed well, with a mean birth weight of 3482 g.
In patients with submucous leiomyomas, pregnancies and full-term deliveries can be successfully achieved following USgHIFU, with few related complications.
探讨超声引导下高强度聚焦超声(USgHIFU)对黏膜下平滑肌瘤患者妊娠的影响。
2015年10月至2021年10月,在中国川北医学院附属医院对32例接受USgHIFU治疗后妊娠的黏膜下平滑肌瘤患者进行了一项回顾性观察研究。分析了妊娠结局、黏膜下平滑肌瘤特征及USgHIFU参数。
共成功分娩17例(53.1%),其中16例(94.1%)足月分娩,1例(5.9%)早产。USgHIFU治疗后,32例患者宫腔内有效体积及黏膜下平滑肌瘤体积均缩小。USgHIFU治疗后至妊娠的中位时间为11.0个月。妊娠前,13例(40.6%)患者肌瘤类型降级,10例(31.3%)稳定,9例(28.1%)升级。黏膜下平滑肌瘤经阴道排出率为28.1%,其中3例(9.4%)完全排出,6例(18.8%)部分排出。USgHIFU治疗后,各孕期黏膜下平滑肌瘤大小均未增加(均P>0.05)。妊娠期间高并发症发生率(7/17,41.2%)与产妇高龄有关,仅1例(5.9%)胎膜早破可能与黏膜下平滑肌瘤有关。阴道分娩6例(35.5%),剖宫产11例(64.7%)。17例新生儿均发育良好,平均出生体重3482g。
黏膜下平滑肌瘤患者接受USgHIFU治疗后可成功妊娠及足月分娩,相关并发症较少。